vorasidenib
servier
['indigo', 'vorasidenib', 'servier']
indigo trial of 's idh1/2 inhibitor vorasidenib at #asco23 raises hope of a targeted therapy for hard-to-treat brain cancer low-grade #glioma, but liver tox is a concern 
https://t.co/O0ZJQGuINh, and its digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate